1018473-22-7 Usage
Uses
Used in Pharmaceutical Industry:
1-(6-chloropyrimidin-4-yl)-3-methyl-1H-pyrazol-5-amine is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to exhibit interesting biological activities. Its unique structure allows it to be a valuable component in the development of new drugs with specific therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(6-chloropyrimidin-4-yl)-3-methyl-1H-pyrazol-5-amine is utilized as a building block in the creation of agrochemicals. Its reactivity and chemical properties make it suitable for the development of compounds that can be used in crop protection and other agricultural applications.
Used in Organic Chemistry:
1-(6-chloropyrimidin-4-yl)-3-methyl-1H-pyrazol-5-amine serves as an important intermediate in organic chemistry for the production of a wide range of chemical products. Its versatility in reactions and ability to form various derivatives contribute to its significance in the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 1018473-22-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,8,4,7 and 3 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1018473-22:
(9*1)+(8*0)+(7*1)+(6*8)+(5*4)+(4*7)+(3*3)+(2*2)+(1*2)=127
127 % 10 = 7
So 1018473-22-7 is a valid CAS Registry Number.
1018473-22-7Relevant articles and documents
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
-
Page/Page column 81, (2008/06/13)
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, ARG, BCR-Abl, BRK, EphB, Fms, Fyn, KDR, c-Kit, LCK, PDGF-R, b-Raf, c-Raf, SAPK2, Src, Tie2 and TrkB kinases.